U
BPTH

UBS’s Bio-Path Holdings Inc BPTH Stock Holding History

UBS’s Portfolio BPTH Stock Details BPTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$7K Buy
+1
New +$9.65K ﹤0.01% 9192

Other funds holding BPTH

UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $863M AUM 30.35% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

UBS's BPTH Position: Q3 2014 in Review

UBS opened a new position in Bio-Path Holdings Inc (BPTH) in Q3 2014: 1 share worth $7K. The stake represents ﹤0.01% of the portfolio and ranks #9192 among its holdings.

38 funds tracked by Wall St. Rank hold BPTH as of Q3 2014.

  • UBS held 1 share of Bio-Path Holdings Inc worth $7K as of Q3 2014.
  • Bio-Path Holdings Inc was a new UBS position in Q3 2014.
  • Bio-Path Holdings Inc made up ﹤0.01% of UBS's portfolio in Q3 2014, its #9192 holding.
  • 38 funds tracked by Wall St. Rank held Bio-Path Holdings Inc as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.